Individualizing Sun-Safety Counseling: Matching Patient Goals With Cancer RiskByJoshua Arbesman, MD,Marie Bosslett, Assistant EditorSeptember 4th 2026
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD PipelineByShannon Heaning, Content AssociateSeptember 3rd 2026